Neuralink focuses on the development of brain-computer interfaces. The company's main product is a fully implantable brain-computer interface designed to restore autonomy to individuals with unmet medical needs, such as quadriplegia, by enabling them to control computers and mobile devices with their thoughts. It primarily serves the medical technology and neuroscience sectors. It was founded in 2016 and is based in Fremont, California.
ESPs containing Neuralink
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The medical brain-computer interfaces (BCIs) market offers innovative solutions for patients with neurological disorders. BCIs are devices that allow direct communication between the brain and an external device, such as a computer or prosthetic limb. This technology has the potential to revolutionize the way we treat conditions such as paralysis, epilepsy, and Parkinson's disease. BCIs can also b…
Research containing Neuralink
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Neuralink in 2 CB Insights research briefs, most recently on Sep 6, 2022.
Neuralink has filed 29 patents.
Image processing, Surgery, Feature detection (computer vision), Computer vision, 3D imaging
Image processing, Surgery, Feature detection (computer vision), Computer vision, 3D imaging
Latest Neuralink News
Dec 5, 2023
News provided by Share this article Share toX Targeting global high-net-worth investors and family offices, Velvet aims to facilitate transactions of up to $250 million on the platform in 2024 The partnership brings Templum's infrastructure to enable investments by international offshore investors in category defining companies such as SpaceX, OpenAI, and Neuralink NEW YORK & SAO PAULO, Dec. 5, 2023 /PRNewswire/ -- Velvet , a company specializing in the buying and selling of equity in high-growth technology companies, has just announced the beta launch of its secondary marketplace. This initiative is in collaboration with Templum , the leading global infrastructure for private markets and alternative assets. Through the jointly created platform, offshore investors will have the opportunity to invest in disruptive private companies such as SpaceX, OpenAI and Neuralink. The projected transaction volume for 2024 is $250 million, representing a sevenfold increase from Velvet's 2023 transaction value. To reach this goal, Velvet will continue building partnerships with global private banks and open an office in the Middle East to cater to a growing base of investors in the region. Velvet announces the beta launch of its secondary marketplace. This initiative is in collaboration with Templum. Velvet clients will have access to Templum One, a central operating system for private markets that simplifies access to alternative assets, making trading in otherwise illiquid assets as easy as buying public stocks. A highly secure ecosystem, the solution connects issuers, investors, custodians, transfer agents and other industry stakeholders. The goal is to make alternative assets and private securities available to a broader range of investors. Key features of the marketplace include a curated list of detailed information on each of the wide array of available assets, such as alternative investments for its customer base, frictionless investor account maintenance through integration and support and an expedited standard purchase process, including consolidated payments and management. "Our focus is to bring new opportunities to global offshore investors starting by giving them access to equity in truly exponential companies such as SpaceX, which, through the constellation of low orbit satellites from its subsidiary StarLink, is changing how humanity consumes data. Another example is OpenAI, which is leading the revolution in Artificial Intelligence with products like ChatGPT," said Carlos Naupari, founder and CEO of Velvet. "In the current market recovery scenario, we aim to concentrate on technology companies that will have a long-term impact globally and consequently bring outsized returns to investors," he adds. Velvet aims to provide exclusive and high-potential opportunities to ultra-high-net-worth investors who already possess a diversified and sophisticated portfolio. The minimum ticket for new investments will be USD 100,000 and the investment structure will be done via Delaware based entities. "The United States is a global leader in public markets and still the main exporter of category defining companies in cutting-edge fields such as artificial intelligence and space exploration," said Christopher Pallotta, founder and CEO of Templum. "The partnership between Templum and Velvet enables offshore global investors to invest in privately held American companies through an institutional-grade trading platform designed specifically for the private markets." About Velvet: Founded in 2021, in São Paulo / Brazil, Velvet's mission is to provide exclusive access to high-potential, privately held technology companies for qualified offshore investors. In partnership with Templum, the company offers a fully regulated, transparent and efficient secondary marketplace for trading equity interests in alternative assets, equipped with cutting-edge tools, data and insights to connect all market participants and assist with decision-making. Velvet's goal is to simplify and optimize access, distribution and fundraising of alternative assets for private bankers, wealth managers and family offices around the globe. About Templum: Templum is the operating system for private markets and alternative assets and is paving the way for investors to participate in new asset classes through integrated market technologies and APIs for primary issuance, secondary trading, alternative data and Templum One, our private markets and alternative assets ecosystem solution. Templum's combined solutions improve efficiency and access in private markets by enabling seamless, electronic workflows for alternative investments and standardized infrastructure to support operations, rather than the fragmented manual processes currently used in private markets. We unify private market infrastructure, investment opportunities and investor capital, into a single solution for private securities and alternative assets. Templum Markets LLC. a wholly owned subsidiary of Templum, Inc., is a New York-based broker-dealer, and Alternative Trading System (ATS) approved to trade unregistered private securities in 53 U.S. states and territories. For more information, please visit www.templuminc.com . SOURCE Velvet
Neuralink Frequently Asked Questions (FAQ)
When was Neuralink founded?
Neuralink was founded in 2016.
Where is Neuralink's headquarters?
Neuralink's headquarters is located at 7400 Paseo Padre Parkway, Fremont.
What is Neuralink's latest funding round?
Neuralink's latest funding round is Series D.
How much did Neuralink raise?
Neuralink raised a total of $679.7M.
Who are the investors of Neuralink?
Investors of Neuralink include Founders Fund, Craft Ventures, Gigafund, Samuel Harris Altman, Valor Equity Partners and 12 more.
Who are Neuralink's competitors?
Competitors of Neuralink include Kernel, .lumen, Paradromics, Synchron, Neurosity and 7 more.
Compare Neuralink to Competitors
Kernel focuses on neuroscience, operating within the healthcare and technology sectors. The company's main offerings include proprietary neurotechnology used to build a portfolio of brain-based biomarkers, accelerate treatment discovery, improve patient outcomes, and transform neuro medicine. Kernel primarily serves the healthcare industry, specifically the neuro medicine sector. It was founded in 2016 and is based in Culver City, California.
Blackrock Neurotech is a company focused on the development of neurotechnology, specifically in the field of implantable brain-computer interfaces. The company's main offerings include devices that restore function and independence to individuals with neurological disorders, enabling them to perform tasks such as eating, drinking, sending emails, and operating robotic arms using their thoughts. Blackrock Neurotech primarily serves the healthcare and research sectors, with a particular focus on neurological disorders and paralysis. It was founded in 2008 and is based in Salt Lake City, Utah.
Synchron operates as a medical device company focusing on the development of minimally invasive neuromodulation technology solutions. It develops an endovascular brain-computer interface that can access every corner of the brain using the blood vessels. It offers Synchron’s switch device to help paralyzed people, such as those with amyotrophic lateral sclerosis (ALS), communicate by controlling computer cursors with their minds. The company was founded in 2016 and is based in Brooklyn, New York.
Paradromics provides data-rate brain-computer interfaces (BCI). It aims to enable treatment options for neurodegenerative diseases and advanced neuroprosthetic limbs for those suffering from amputation and spinal cord injuries. The company was founded in 2015 and is based in Austin, Texas.
Neurable develops brain-computer interface (BCI) technology. It uses electroencephalogram (EEG) activity and builds an intelligent layer between the brain and computers. It focuses on building hardware and devices to measure brain activity and provide actionable insights. The company was founded in 2016 and is based in Boston, Massachusetts. .
NURO develops a neurological platform allowing non-invasive communication and computing control by the brain. It permits any human being to communicate and compute through the brain. The company was founded in 2017 and is based in Waterloo, Canada.